SIA "SAULES APTIEKA"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
from the reportDividends paid 392 000 € (5% of equity at the end of the previous year).
Summary of financial statements2011–2025
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||||||
| Total current assets | 874 201 | 1 425 728 | 836 089 | 1 626 422 | 3 084 514 | 4 634 415 | 4 601 819 | 6 792 663 | 2 475 751 | 2 885 944 | 3 728 833 | 4 309 340 | 4 519 174 | 4 510 975 | 5 345 060 |
| Total non-current assets | 305 161 | 327 631 | 2 033 664 | 3 466 913 | 3 444 631 | 3 433 559 | 3 310 393 | 3 449 486 | 7 723 356 | 8 303 425 | 8 463 018 | 8 348 715 | 8 069 996 | 7 764 431 | 7 916 300 |
| Total assets | 1 179 362 | 1 753 359 | 2 869 753 | 5 093 335 | 6 529 145 | 8 067 974 | 7 912 212 | 10 242 149 | 10 199 107 | 11 189 369 | 12 191 851 | 12 658 055 | 12 589 170 | 12 275 406 | 13 261 360 |
| Balance sheet — liabilities and equity | |||||||||||||||
| Current liabilities | 637 988 | 870 814 | 979 457 | 2 122 047 | 2 042 690 | 1 705 753 | 1 455 043 | 2 037 957 | 3 719 878 | 3 996 499 | 4 112 906 | 3 937 427 | 3 150 148 | 3 443 781 | 3 801 706 |
| Non-current liabilities | 12 101 | 8068 | 992 425 | 912 035 | 1 774 423 | 3 461 007 | 3 090 783 | 3 885 157 | 2 971 796 | 2 970 889 | 2 743 000 | 2 343 000 | 2 132 491 | 1 523 141 | 1 074 092 |
| Total liabilities | 650 089 | 878 882 | 1 971 882 | 3 034 082 | 3 817 113 | 5 166 760 | 4 545 826 | 5 923 114 | 6 691 674 | 6 967 388 | 6 855 906 | 6 280 427 | 5 282 639 | 4 966 922 | 4 875 798 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 343 681 | 675 738 | 702 100 | 785 646 | 942 846 | 924 608 | 915 239 | 1 114 649 | 2 136 668 | 1 363 548 | 1 293 964 | 1 117 683 | 1 383 403 | 1 066 953 | 1 469 078 |
| Total equity | 529 273 | 861 330 | 882 100 | 2 040 761 | 2 683 607 | 2 901 214 | 3 366 386 | 4 319 035 | 3 507 433 | 4 221 981 | 5 335 945 | 6 377 628 | 7 306 531 | 7 308 484 | 8 385 562 |
| Income statement | |||||||||||||||
| Sales revenue | 5 252 441 | 7 964 258 | 8 761 618 | 13 925 106 | 16 671 399 | 18 030 471 | 19 961 340 | 19 328 077 | 20 126 367 | 26 052 690 | 21 649 667 | 22 990 450 | 28 076 383 | 26 947 871 | 29 751 891 |
| Operating profit | 398 552 | 793 785 | 861 274 | 1 040 098 | 1 049 917 | 900 478 | 1 126 040 | 1 094 174 | 1 532 267 | 1 249 473 | 768 797 | 410 766 | 1 226 431 | 749 867 | 1 001 079 |
| Profit before income tax | 405 183 | 800 602 | 820 572 | 934 339 | 1 099 870 | 1 044 626 | 1 044 657 | 1 119 699 | 2 138 880 | 1 366 486 | 1 295 769 | 1 117 796 | 1 383 725 | 1 068 952 | 1 469 456 |
| Profit for the reporting year | 343 681 | 675 738 | 702 100 | 785 646 | 942 846 | 924 608 | 915 239 | 1 114 649 | 2 136 668 | 1 363 548 | 1 293 964 | 1 117 683 | 1 383 403 | 1 066 953 | 1 469 078 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||||||
| Employees | 31 | 37 | 45 | 49 | 55 | 61 | 70 | 72 | 71 | 66 | 69 | 80 | 86 | 90 | 85 |
| Calculated dividend | 190 634 | 343 681 | 681 330 | 0 | 300 000 | 707 000 | 450 067 | 162 000 | 2 948 270 | 649 000 | 180 000 | 76 000 | 454 500 | 1 065 000 | 392 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
- SIA "Saules Veselības centrs" — 100%
- Sabiedrība ar ierobežotu atbildību "ANNO" — 100%
- Sabiedrība ar ierobežotu atbildību "ZEMITĀNI" — 100%
- SIA Pharmabaltix — 50,17%
- SIA "Baltacon" — 50%
- SIA "KANINS" — 50%
- Latvijas Aptiekāru asociācija — 2 shared people
- SIA "Contract Pharma" — 2 shared people
- SIA "JAUNIE EZERKRASTI" — 2 shared people
- "CILMES ŠŪNU TEHNOLOĢIJU UN SPECIĀLISTU ASOCIĀCIJA"
- "Eksporta 12"
- SIA "2012"
- SIA "ABC pharma"
- SIA "Baltacon"
- SIA "GLOBAL FINANCE HQ"
- SIA "INNOVATIVE BUSINESS CONSULTING"
- SIA "KANINS"
- SIA "Nexus Global"
Summary: SIA "SAULES APTIEKA"
Overview
SIA "SAULES APTIEKA" (reg. no. 40003373494) is a limited liability company. The company was registered in 1998 and has been in the register for 28 years. Registered address: Rīga, Krūzes iela 38.
Financial results
Revenue in 2025 was 29 751 891 €, up 10,4% on the previous year (26 947 871 €). From 2011 to 2025, revenue grew by an average of 13,2% per year. This is the company's highest revenue among the published years (2011–2025). Net profit for 2025 was 1 469 078 € (4,9% of revenue). The company was profitable in all 15 published years. In 2025 the company had 85 employees (90 a year earlier). Revenue per employee was 350 022 €. At the end of 2025, total assets were 13 261 360 € and equity 8 385 562 € (63,2% of assets).
Management and owners
The board has 4 members. The sole owner of the company is a private individual. The company holds stakes in 6 active Latvian companies.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.